Patient Preferences for Time and Location of Infusible Therapies in Multiple Sclerosis and Neuroimmunologic Disorders.
Rath L, Campagna MP, Stankovich J, Ellis J, Jokubaitis V, McCarthy D, Nesbitt C, Yeh WZ, Zhong M, Wesselingh R, Monif M, Richards J, Minh VB, Skibina O, Butzkueven H, van der Walt A.
Rath L, et al. Among authors: monif m.
Int J MS Care. 2021 May-Jun;23(3):114-118. doi: 10.7224/1537-2073.2020-075. Epub 2020 Dec 31.
Int J MS Care. 2021.
PMID: 34177383
Free PMC article.